Follow The Filings

ACCS ACCESS Newswire

ACCESS Newswire earnings company data as of 4:48 AM ET 10/23

Scheduled

1 period, newest first, nothing reported yet. Each row shows EPS above revenue.

Period Date Metric Estimate Actual Result
FY2026 Q3 10 Nov EPS 0.09 — —
Rev — — —

Insider trades

Open-market buys and sales by ACCS's executives, directors and 10% owners in the last 12 months, from their Form 4s

All ACCS insider trades
  • $412K bought by 3 insiders
  • None no sales outside a trading plan
  • None no planned (10b5-1) sales
  1. Graeme P. Rein Director
    Buy
    $30K 6,000 shares at $4.95 +6.2% to stake
    Traded Aug 24 Filed Aug 24
  2. Graeme P. Rein Director
    Buy
    $49K 9,700 shares at $5.10 +11% to stake
    Traded Aug 17 Filed Aug 18
  3. Brian R Balbirnie CEO
    Buy
    $50K 10,000 shares at $4.95 +1.6% to stake
    Traded Aug 14 Filed Aug 17
  4. Wesley T Pollard Director
    Buy
    $9,980 2,000 shares at $4.99 +14% to stake
    Traded Aug 14 Filed Aug 17
  5. Brian R Balbirnie CEO
    Buy
    $12K 1,750 shares at $6.70 +0.3% to stake
    Traded Jun 23 Filed Jun 24
  6. Wesley T Pollard Director
    Buy
    $6,250 1,000 shares at $6.25 +9.3% to stake
    Traded Jun 3 Filed Jun 22
  7. Brian R Balbirnie CEO
    Buy
    $65K 10,000 shares at $6.46 +1.6% to stake
    Traded May 27 Filed May 29
  8. Graeme P. Rein Director
    Buy
    $46K 7,267 shares at $6.31 +9.1% to stake
    Traded May 26 Filed May 27
  9. Graeme P. Rein Director
    Buy
    $101K 14,833 shares at $6.80 +23% to stake
    Traded May 15–18 Filed May 19
  10. Wesley T Pollard Director
    Buy
    $7,000 1,000 shares at $7.00 +10% to stake
    Traded May 15 Filed May 18
  11. Wesley T Pollard Director
    Buy
    $11K 1,500 shares at $7.29 +26% to stake
    Traded Mar 25 Filed Mar 30
  12. Brian R Balbirnie CEO
    Buy
    $26K 3,396 shares at $7.54 +0.5% to stake
    Traded Mar 25 Filed Mar 26

SEC filings

Recent issuer filings from EDGAR, 19 shown.

Filed Form Detail Links
8-K 2.02,9.01
10-Q FORM 10-Q FOR JUN 2026
8-K 5.07
SCHEDULE 13D/A —
8-K 2.02,9.01
10-Q FORM 10-Q FOR MAR 2026
DEF 14A DEFINITIVE PROXY STATMENT
8-K 2.02,9.01
10-K FORM 10-K FOR DEC 2025
8-K 5.02
8-K 8.01,9.01
8-K 2.02,9.01
10-Q FORM 10-Q FOR SEP 2025
SCHEDULE 13D —
8-K 2.02,9.01
10-Q FORM 10-Q
8-K 5.07,9.01
8-K/A 2.02,9.01
10-Q FORM 10-Q

Estimates are consensus figures; SEC filings remain the official record. Not investment advice.